Lincoln created an exceptional transaction for the shareholders of Choice Health. Lincoln’s expertise in the insurance distribution and marketing services sectors and contacts within the buyer universe, combined with a well-orchestrated process by a team of highly dedicated senior bankers, allowed us to achieve an optimal outcome.
Meet our Senior Team
I listen to my clients to understand their needs, gain insight on opportunities they see within their industry, connect with what inspires them about their business and then collaboratively work to articulate the value of their business to the market in order to drive a successful outcome.
Moyo Mamora
Director
ChicagoView More Transactions
Lincoln International represents Choice Health in its sale to Alight Solutions, a portfolio company of Blackstone
Founded in 2003 and headquartered in Myrtle Beach, South Carolina, Choice Health specializes generating leads and brokering policies in the Medicare Advantage marketplace covering over 24 million senior citizens in… Read More
Satori Capital has sold Longhorn Health Solutions to Riverglade Capital
Client: Satori Capital Client Location: United States Target: Longhorn Health Solutions Target Location: United States Buyer: Riverglade Capital Buyer Location: United States Target Description: Longhorn Health Solutions, Inc. is a leading… Read More
Lincoln International Releases Proprietary Q2 2020 Middle Market Index
Sponsors and lenders remain supportive of their portfolio companies as the impacts of COVID-19 persist Liquidity becomes focal point as portfolio companies feel the effects of the pandemic while middle… Read More
Lincoln International Adds Two Healthcare Managing Directors
Caliber of Experience & Reputation Strengthens Firm’s Growing Healthcare Capability Lincoln International today announced that two experienced mergers and acquisitions (M&A) advisors have joined the firm’s Healthcare Group as Managing… Read More
Roderick O’Neill
Roddy is Managing Director and Co-Head of Lincoln’s Healthcare Group in the U.S. He has more than 27 years of investment banking expertise in the healthcare services sector and significant… Read More
Emily Wildes
As Co-Head of Lincoln’s Healthcare Group in the U.S., Emily leads the firm’s healthcare initiatives and provides mergers and acquisitions (M&A) advisory services to global clients, with an emphasis on… Read More
Andreas Roth
Andy provides mergers and acquisitions (M&A) advisory services to entrepreneurs, corporates and private equity funds both on sell-side and buy-side assignments with a focus on Switzerland and throughout Europe. Andy… Read More
Wall Street Journal | Medical-Device Investment Rises in Second Quarter
Brian Bock, Lincoln International Managing Director, discusses with the The Wall Street Journal how investments in the medical device sector have been impacted by the #COVID19 pandemic and the expectation that they should rise… Read More
UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S
View extended case study here Lincoln acted as the exclusive financial advisor for UAS Laboratories, working closely with its shareholders and management throughout the sale process. This included providing advisory… Read More
Doppel Farmaceutici, an Italian portfolio company of Trilantic Europe, has acquired Dietopack
Trilantic Europe’s portfolio company, Doppel Farmaceutici, has acquired 90% of Dietopack, a leading Italian contract development and manufacturing organization (CDMO). Doppel’s acquisition of Dietopack creates a larger, more diversified and… Read More
HealthEZ Has Completed a Majority Recapitalization by Abry Partners
Founded in 1982 by industry luminary Nazie Eftekhari and headquartered in Minneapolis, Minnesota, HealthEZ is driven by the principles of simplifying and making more transparent the byzantine process of accessing… Read More
Lincoln International Adds Three Healthcare Investment Banking Leaders
Lincoln International, a leading global investment banking advisory firm, today announced that three leaders specializing in mergers and acquisitions (M&A) advisory for the healthcare sector have joined the firm’s Frankfurt… Read More
Dirk-Oliver Löffler
Dirk co-heads Lincoln International’s Healthcare Group in Europe and leads the firm’s mergers and acquisitions (M&A) advisory efforts in that industry. He executes sell-side and buy-side M&A transactions for private… Read More
Jens Gerlach
Jens provides mergers and acquisitions (M&A) advisory to clients across the entire healthcare spectrum. He has experience in complex sell-side and buy-side transactions, as well as capital advisory engagements, and… Read More
Julian Knirim
Julian advises shareholders, management teams and financial sponsors on complex private and public mergers and acquisitions (M&A) transactions in the global healthcare sector. He has extensive experience in sell-side and… Read More
Webinar | UK Nursery Sector: Navigating the Financing Market in the COVID-19 Environment
On May 21, 2020, a panel of Lincoln International’s European capital advisory and healthcare experts discussed the impact of COVID-19 on financing markets in the nursery sector. Topics covered include:… Read More
Gruppo Sapio has acquired a majority stake in Homeperf
Founded in 1997, Homeperf is one of the leading players in the French home care services sector, offering infusion, nutrition, insulin and respiratory assistance services. The group operates a network… Read More
Awakening of the Healthcare Consumer
Since the beginning of the Information Age, there has been discussion around the importance, emergence, and empowerment of the health care consumer. This has been enabled and driven by rapid… Read More
Lincoln International Releases Proprietary Q1 2020 Middle Market Index
Published by Bloomberg on May 7, 2020 here. As companies navigate COVID-19, middle market enterprise values fare better than the S&P 500 No industry sector was spared by the declines… Read More
IntegriChain has acquired the life sciences division of Cumberland
Lincoln International served as the exclusive financial advisor and debt arranger to IntegriChain on the acquisition, providing industry expertise, valuation and strategic guidance on the key investment thesis, proactively addressing… Read More
Outlook of COVID-19 Impact on Global Medtech M&A / Business Development
The Current Environment – Commentary COVID-19 is delivering a true one-two punch to the economy. The first punch stunned global markets with a complete shut-down of activity, but coming out… Read More
Ophthalmology Sector Thesis Strongly Intact with Demand Build-up Amidst COVID-19
Across the world, individuals are prioritizing human health and safety amidst the coronavirus pandemic, but hope is starting to dawn as countries, like Germany and the Czech Republic, begin easing… Read More
Pharmacies: The Right Prescription for Investors
Prior to the effects of COVID-19, UK community pharmacies were already undergoing significant change as a range of factors converge to transform the role of pharmacists within the primary care… Read More
Interim/Post-COVID-19 Sector Outlook: Services & Products for Homebound Patients
Click the home healthcare sectors below to view key takeaways on the effects of COVID-19. Medical and Personal Services Skilled Home Healthcare Near term: REASONABLY STABLE / POSITIVE Long term:… Read More
Valeritas has Completed a Section 363 Asset Sale to Zealand Pharma
Valeritas Holdings, Inc. (NASDAQ:VLRX) is a publicly traded, commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes by developing and commercializing innovative technologies. Valeritas’… Read More